The use of atezolizumab in combination with chemotherapy in first-line of metastatic small cell lung cancer. Case report

par Nikolai A. Ognerubov, Tatyana S. Antipova
Publié 2021

Morphine promotes the malignant biological behavior of non-small cell lung cancer cells through the MOR/Src/mTOR pathway

par Xingyun Liu, Jia Yang, Chengwei Yang, Xiang Huang, Mingming Han, Fang Kang, Juan Li
Publié 2021

Outcomes and prognostic factors of chemotherapy for patients with locally advanced or metastatic pulmonary squamous cell carcinoma

par Minami S, Ogata Y, Ihara S, Yamamoto S, Komuta K
Publié 2016

HER2 Amplification in Advanced NSCLC Patients After Progression on EGFR-TKI and Clinical Response to EGFR-TKI Plus Pyrotinib Combination Therapy

par Gan J, Huang Y, Liao J, Pang L, Fang W
Publié 2021

Premalignant Changes in the Bronchial Epithelium Are Prognostic Factors of Distant Metastasis in Non-Small Cell Lung Cancer Patients

par Olga V. Pankova, Liubov A. Tashireva, Evgeny O. Rodionov, Sergey V. Miller, Sergey A. Tuzikov, Dmitry S. Pismenny, Tatiana S. Gerashchenko, Marina V. Zavyalova, Marina V. Zavyalova, Sergey V. Vtorushin, Sergey V. Vtorushin, Evgeny V. Denisov, Evgeny V. Denisov, Vladimir M. Perelmuter
Publié 2021

Effect of Epigallocatechin-3-Gallate on EGFR Signaling and Migration in Non-Small Cell Lung Cancer

par Cristina Minnelli, Laura Cianfruglia, Emiliano Laudadio, Giovanna Mobbili, Roberta Galeazzi, Tatiana Armeni
Publié 2021

Detection of disseminated tumor cells and their relationship with a population of bone marrow lymphocytes in patients with non-small cell lung cancer

par T. M. Djumanazarov, S. V. Chulkova, N. N. Tupitsyn, O. A. Chernysheva, A. K. Allakhverdiev, A. D. Palladina, N. A. Kupryshina, O. P. Kolbatskaya, P. V. Kononetz, B. B. Akhmedov, S. S. Gerasimov
Publié 2020

The Prognostic Role of Blood Inflammatory Biomarkers and EGFR Mutation Status in Stage IIIA/N2 Non-Small Cell Lung Cancer Patients Treated With Trimodality Therapy

par Hui Yang, Kunlun Wang, Bingxu Li, Bingxu Li, Shenglei Li, Yan Li, Ling Yuan
Publié 2021

Trajectory of chemotherapy for patients with EGFR wild-type advanced pulmonary adenocarcinoma: a single-institution retrospective study

par Minami S, Ogata Y, Ihara S, Yamamoto S, Komuta K
Publié 2017

Silencing of the lncRNA H19 enhances sensitivity to X-ray and carbon-ions through the miR-130a-3p /WNK3 signaling axis in NSCLC cells

par Xueshan Zhao, Xiaodong Jin, Qiuning Zhang, Ruifeng Liu, Hongtao Luo, Zhen Yang, Yichao Geng, Shuangwu Feng, Chengcheng Li, Lina Wang, Xiaohu Wang, Qiang Li
Publié 2021

Impact of Genetic Polymorphisms on the Metabolic Pathway of Vitamin D and Survival in Non-Small Cell Lung Cancer

par Laura Elena Pineda Lancheros, Cristina Pérez Ramírez, Almudena Sánchez Martín, José María Gálvez Navas, Fernando Martínez Martínez, María del Carmen Ramírez Tortosa, Alberto Jiménez Morales
Publié 2021

Radiation pneumonitis in patients with non-small-cell lung cancer receiving chemoradiotherapy and an immune checkpoint inhibitor: a retrospective study

par Jeong Yun Jang, Su Ssan Kim, Si Yeol Song, Yeon Joo Kim, Sung-woo Kim, Eun Kyung Choi
Publié 2021

m6A regulators as predictive biomarkers for chemotherapy benefit and potential therapeutic targets for overcoming chemotherapy resistance in small-cell lung cancer

par Zhihui Zhang, Chaoqi Zhang, Zhaoyang Yang, Guochao Zhang, Peng Wu, Yuejun Luo, Qingpeng Zeng, Lide Wang, Qi Xue, Yi Zhang, Nan Sun, Jie He
Publié 2021

Clinical Practice of Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitor Targeted Drugs Combined with Gadolinium Oxide Nanoparticles in the Treatment of Non-Small Cell Lung...

par Xuan Zhou, Ting Jin, Likun Wang, Erlin Zhao, Xuyang Xiao
Publié 2021

Pretreatment Glasgow prognostic score and prognostic nutritional index predict overall survival of patients with advanced small cell lung cancer

par Minami S, Ogata Y, Ihara S, Yamamoto S, Komuta K
Publié 2017

Dual immunological blockade in the treatment of metastatic non-small cell lung cancer: reality and perspectives

par Denis I. Yudin, Konstantin K. Laktionov, Liudmila V. Laktionova, Valeriy V. Breder
Publié 2021

Prognostic value of soluble major histocompatibility complex class I polypeptide-related sequence A in non-small-cell lung cancer – significance and development

par Cascone R, Carlucci A, Pierdiluca M, Santini M, Fiorelli A
Publié 2017